Lipe & Dalton’s ScottsMiracle-Gro SMG Stock Holding History

Lipe & Dalton’s Portfolio SMG Stock Details SMG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-11,950	Closed	-$944K	–	102
2022 Q2	$944K	Sell	11,950 -6,250	-34%	-$618K	0.55%	50
2022 Q1	$2.24M	Buy	+18,200	New	+$2.55M	1.09%	34

Other funds holding SMG

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Lipe & Dalton's SMG Position: Q3 2022 in Review

Lipe & Dalton sold out of ScottsMiracle-Gro (SMG) in Q3 2022, closing a stake of 11,950 shares — an estimated $944K sold.

Lipe & Dalton first reported a position in SMG in Q1 2022 and held it in 2 quarters. The position peaked at $2.24M in Q1 2022. 415 funds tracked by Wall St. Rank hold SMG as of Q3 2022.

Lipe & Dalton reported no remaining ScottsMiracle-Gro position as of Q3 2022 after selling out during the quarter.
Lipe & Dalton sold 11,950 ScottsMiracle-Gro shares in Q3 2022, an estimated $944K.
Lipe & Dalton first reported a position in ScottsMiracle-Gro in Q1 2022 and held it in 2 quarters.
Lipe & Dalton's ScottsMiracle-Gro position peaked at $2.24M in Q1 2022.
415 funds tracked by Wall St. Rank held ScottsMiracle-Gro as of Q3 2022.

Based on Lipe & Dalton's 13F filing for Q3 2022, filed 7 Nov 2022.